1 completed, 1 recruiting, 1 withdrawn. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 1, Recruiting 1, Withdrawn 1 |
| Phase 2 | 2 | Recruiting 1, Withdrawn 1 |
Follow Topical infliximab: new trials by email Literature Review of Topical infliximab trials Research Report on Topical infliximab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Topical Infliximab in Eyes With Penetrating Keratoplasty Topical infliximab, No topical infliximab - Glaucoma Following Surgery | Phase 1 / Phase 2 | Recruiting | Centre hospitalier de l'Université de Montréal (CHUM) | 50 | 2022-05-01 | 2026-04-27 |
| Topical Infliximab for Sterile Corneal Melt Topical Infliximab - Sterile Corneal Melt | Phase 1 | Completed | Centre hospitalier de l'Université de Montréal (CHUM) | 7 | 2017-09-06 | 2026-04-28 |
| Topical Infliximab in Autoimmune Eyes With Keratoprosthesis topical infliximab - Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis (Lyell) Syndrome | Phase 1 / Phase 2 | Withdrawn | James Chodosh, MD, MPH | 2014-11-01 | 2017-04-07 |
Corneal Diseases (1) · Pemphigoid, Benign Mucous Membrane (1) · Stevens-Johnson Syndrome (1) · Syndrome (1)
Centre hospitalier de l'Université de Montréal (CHUM) (2) · James Chodosh, MD, MPH (1)
Canada (3) · United States (1)
Marie-Claude Robert, MD (2) · Claes H Dohlman, MD, PhD (1) · James Chodosh, MD, MPH (1) · Mona Harissi-Dagher, MD (1)